Global Laser Cancer Therapy Market

Laser Cancer Therapy Comprehensive Study by Application (Dermatology and Aesthetics, Dental, Ophthalmology, Cardiovascular, Others), End-users (Hospitals, Specialty Clinics, Cancer and Radiation Therapy Centers), Laser Therapy (Carbon dioxide (CO2) lasers, Argon lasers, Nd: Yag lasers), Cancer (Blood Cancer, Breast Cancer, Prostate Cancer, Gastrointestinal Cancer, Others) Players and Region - Global Market Outlook to 2030

Laser Cancer Therapy Market by XX Submarkets | Forecast Years 2024-2030  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
Laser Cancer Therapy Market Scope
Laser remedy makes use of an intense, slender beam of mild to cast off or damage most cancers and odd cells that can flip into cancer. Tumor cells take in mild of distinctive wavelengths (or colors) than everyday cells do. So, tumor cells can be focused by using deciding on the ideal wavelength of the laser. Laser remedy is a type of nearby treatment, which potential it treats a unique phase of body. Lasers can additionally be used in different kinds of neighborhood treatment, which includes photodynamic remedy and a therapy that is like hyperthermia, known as laser interstitial thermal therapy, or LITT. Laser remedy is most regularly used to deal with cancers and precancers on the floor of the physique or the lining of interior organs. Laser remedy makes use of a very narrow, targeted beam of mild to reduce or smash most cancers cells. It can be used to reduce out tumors besides destructive different tissue. and Laser remedy is regularly given thru a thin, lighted tube that is put interior the body. Thin fibers at the cease of the tube direct the mild at the most cancers cells. Lasers are additionally used on the skin.

AttributesDetails
Study Period2018-2030
Base Year2023
UnitValue (USD Million)
Key Companies ProfiledBiolase Inc. (United States), Alma Lasers (Israel), Cutera (United States), IRIDEX Corp. (United States), Valeant (Canada), Coherent, Inc. (United States), Angiodynamics, Inc. (United States), Boston Scientific Corporation (United States), BTL (United States) and Meditech International Inc. (BIOFLEX Laser Therapy) (United States)
CAGR%


The market is seeing moderate market players, by seeing huge growth in this market the key leading vendors are highly focusing towards the production technologies, efficiency enhancement and product life. There is various growth opportunity in this market which is captured by leading players via tracking the ongoing process enhancement and huge invest in market growth strategies. Research Analyst at AMA estimates that United States Players will contribute to the maximum growth of Global Laser Cancer Therapy market throughout the predicted period.

Biolase Inc. (United States), Alma Lasers (Israel), Cutera (United States), IRIDEX Corp. (United States), Valeant (Canada), Coherent, Inc. (United States), Angiodynamics, Inc. (United States), Boston Scientific Corporation (United States), BTL (United States) and Meditech International Inc. (BIOFLEX Laser Therapy) (United States) are some of the key players that are part of study coverage. Additionally, the Players which are also part of the research are Baring Private Equity Asia Ltd (Lumenis) (Hong Kong), Biolitec AG UntereViaduktgasse (Austria) and Hologic Inc., (United States).

About Approach
The research aims to propose a patent-based approach in searching for potential technology partners as a supporting tool for enabling open innovation. The study also proposes a systematic searching process of technology partners as a preliminary step to select the emerging and key players that are involved in implementing market estimations. While patent analysis is employed to overcome the aforementioned data- and process-related limitations, as expenses occurred in that technology allows us to estimate the market size by evolving segments as target market from the total available market.

Segmentation Overview
The study have segmented the market of Global Laser Cancer Therapy market by Type , by Application (Dermatology and Aesthetics, Dental, Ophthalmology, Cardiovascular and Others) and Region with country level break-up.

On the basis of geography, the market of Laser Cancer Therapy has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). region held largest market share in the year 2023.

Market Leaders and their expansionary development strategies
In June 2016, Proton therapy systems developer HIL Applied Medical (Jerusalem, Israel) has acquired Nanolabz (Reno, NV), which develops and fabricates smart targets for laser-based proton acceleration
In 2021, Amgen's LUMAKRAS (sotorasib) was once authorised with the aid of the U.S. Food and Drug Administration (FDA) for the remedy of person sufferers with KRAS G12C-mutated domestically superior or metastatic non-small cellphone lung most cancers (NSCLC)., , In 2021, Cadila Healthcare launched Trastuzumab Emtansine, one of the first Antibody Drug Conjugate (ADC) biosimilar for treating each early and superior HER2 high-quality breast cancer., and In 2020, IRIDEX Corporation, a producer of ophthalmic laser-based scientific products, launched an upgraded second-generation model of MicroPulse P3 Device to deal with glaucoma, and the enhancements made to the machine is anticipated to appreciably limit intraocular strain appropriate for glaucoma sufferers besides incisions.


Influencing Trend:
Patient Preference toward LLT

Market Growth Drivers:
Increasing Consumer Preference towards Innovative Laser-Based Technologies and Growing Prevalence of Diseases like Cataract and Arthritis

Challenges:
Laser Equipment Costs a Lot of Money and Is Bulky Compared With the Usual Surgical Tools Used, Not Many Doctors and Nurses Are Trained To Use Lasers and Strict Safety Precautions Must Be Followed In the Operating Room When Lasers Are Used

Restraints:
Risk of Skin Cancer and Accelerated Skin Aging Among Patients and High Cost of Surgeries Limits the Growth of the Laser Therapy

Opportunities:
The Increasing Dependence on the Laser Therapy Market Supports Several Industries

Key Target Audience
Venture Capitalists, Government Bodies, Corporate Entities, Government and Private Research Organizations and Others

Report Objectives / Segmentation Covered

By Application
  • Dermatology and Aesthetics
  • Dental
  • Ophthalmology
  • Cardiovascular
  • Others
By End-users
  • Hospitals
  • Specialty Clinics
  • Cancer and Radiation Therapy Centers

By Laser Therapy
  • Carbon dioxide (CO2) lasers
  • Argon lasers
  • Nd: Yag lasers

By Cancer
  • Blood Cancer
  • Breast Cancer
  • Prostate Cancer
  • Gastrointestinal Cancer
  • Others

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Increasing Consumer Preference towards Innovative Laser-Based Technologies
      • 3.2.2. Growing Prevalence of Diseases like Cataract and Arthritis
    • 3.3. Market Challenges
      • 3.3.1. Laser Equipment Costs a Lot of Money and Is Bulky Compared With the Usual Surgical Tools Used
      • 3.3.2. Not Many Doctors and Nurses Are Trained To Use Lasers
      • 3.3.3. Strict Safety Precautions Must Be Followed In the Operating Room When Lasers Are Used
    • 3.4. Market Trends
      • 3.4.1. Patient Preference toward LLT
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Laser Cancer Therapy, by Application, End-users, Laser Therapy, Cancer and Region (value) (2018-2023)
    • 5.1. Introduction
    • 5.2. Global Laser Cancer Therapy (Value)
      • 5.2.1. Global Laser Cancer Therapy by: Application (Value)
        • 5.2.1.1. Dermatology and Aesthetics
        • 5.2.1.2. Dental
        • 5.2.1.3. Ophthalmology
        • 5.2.1.4. Cardiovascular
        • 5.2.1.5. Others
      • 5.2.2. Global Laser Cancer Therapy by: End-users (Value)
        • 5.2.2.1. Hospitals
        • 5.2.2.2. Specialty Clinics
        • 5.2.2.3. Cancer and Radiation Therapy Centers
      • 5.2.3. Global Laser Cancer Therapy by: Laser Therapy (Value)
        • 5.2.3.1. Carbon dioxide (CO2) lasers
        • 5.2.3.2. Argon lasers
        • 5.2.3.3. Nd: Yag lasers
      • 5.2.4. Global Laser Cancer Therapy by: Cancer (Value)
        • 5.2.4.1. Blood Cancer
        • 5.2.4.2. Breast Cancer
        • 5.2.4.3. Prostate Cancer
        • 5.2.4.4. Gastrointestinal Cancer
        • 5.2.4.5. Others
      • 5.2.5. Global Laser Cancer Therapy Region
        • 5.2.5.1. South America
          • 5.2.5.1.1. Brazil
          • 5.2.5.1.2. Argentina
          • 5.2.5.1.3. Rest of South America
        • 5.2.5.2. Asia Pacific
          • 5.2.5.2.1. China
          • 5.2.5.2.2. Japan
          • 5.2.5.2.3. India
          • 5.2.5.2.4. South Korea
          • 5.2.5.2.5. Taiwan
          • 5.2.5.2.6. Australia
          • 5.2.5.2.7. Rest of Asia-Pacific
        • 5.2.5.3. Europe
          • 5.2.5.3.1. Germany
          • 5.2.5.3.2. France
          • 5.2.5.3.3. Italy
          • 5.2.5.3.4. United Kingdom
          • 5.2.5.3.5. Netherlands
          • 5.2.5.3.6. Rest of Europe
        • 5.2.5.4. MEA
          • 5.2.5.4.1. Middle East
          • 5.2.5.4.2. Africa
        • 5.2.5.5. North America
          • 5.2.5.5.1. United States
          • 5.2.5.5.2. Canada
          • 5.2.5.5.3. Mexico
  • 6. Laser Cancer Therapy: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2023)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Biolase Inc. (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Alma Lasers (Israel)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Cutera (United States)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. IRIDEX Corp. (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Valeant (Canada)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Coherent, Inc. (United States)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Angiodynamics, Inc. (United States)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Boston Scientific Corporation (United States)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. BTL (United States)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Meditech International Inc. (BIOFLEX Laser Therapy) (United States)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
  • 7. Global Laser Cancer Therapy Sale, by Application, End-users, Laser Therapy, Cancer and Region (value) (2025-2030)
    • 7.1. Introduction
    • 7.2. Global Laser Cancer Therapy (Value)
      • 7.2.1. Global Laser Cancer Therapy by: Application (Value)
        • 7.2.1.1. Dermatology and Aesthetics
        • 7.2.1.2. Dental
        • 7.2.1.3. Ophthalmology
        • 7.2.1.4. Cardiovascular
        • 7.2.1.5. Others
      • 7.2.2. Global Laser Cancer Therapy by: End-users (Value)
        • 7.2.2.1. Hospitals
        • 7.2.2.2. Specialty Clinics
        • 7.2.2.3. Cancer and Radiation Therapy Centers
      • 7.2.3. Global Laser Cancer Therapy by: Laser Therapy (Value)
        • 7.2.3.1. Carbon dioxide (CO2) lasers
        • 7.2.3.2. Argon lasers
        • 7.2.3.3. Nd: Yag lasers
      • 7.2.4. Global Laser Cancer Therapy by: Cancer (Value)
        • 7.2.4.1. Blood Cancer
        • 7.2.4.2. Breast Cancer
        • 7.2.4.3. Prostate Cancer
        • 7.2.4.4. Gastrointestinal Cancer
        • 7.2.4.5. Others
      • 7.2.5. Global Laser Cancer Therapy Region
        • 7.2.5.1. South America
          • 7.2.5.1.1. Brazil
          • 7.2.5.1.2. Argentina
          • 7.2.5.1.3. Rest of South America
        • 7.2.5.2. Asia Pacific
          • 7.2.5.2.1. China
          • 7.2.5.2.2. Japan
          • 7.2.5.2.3. India
          • 7.2.5.2.4. South Korea
          • 7.2.5.2.5. Taiwan
          • 7.2.5.2.6. Australia
          • 7.2.5.2.7. Rest of Asia-Pacific
        • 7.2.5.3. Europe
          • 7.2.5.3.1. Germany
          • 7.2.5.3.2. France
          • 7.2.5.3.3. Italy
          • 7.2.5.3.4. United Kingdom
          • 7.2.5.3.5. Netherlands
          • 7.2.5.3.6. Rest of Europe
        • 7.2.5.4. MEA
          • 7.2.5.4.1. Middle East
          • 7.2.5.4.2. Africa
        • 7.2.5.5. North America
          • 7.2.5.5.1. United States
          • 7.2.5.5.2. Canada
          • 7.2.5.5.3. Mexico
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Laser Cancer Therapy: by Application(USD Million)
  • Table 2. Laser Cancer Therapy Dermatology and Aesthetics , by Region USD Million (2018-2023)
  • Table 3. Laser Cancer Therapy Dental , by Region USD Million (2018-2023)
  • Table 4. Laser Cancer Therapy Ophthalmology , by Region USD Million (2018-2023)
  • Table 5. Laser Cancer Therapy Cardiovascular , by Region USD Million (2018-2023)
  • Table 6. Laser Cancer Therapy Others , by Region USD Million (2018-2023)
  • Table 7. Laser Cancer Therapy: by End-users(USD Million)
  • Table 8. Laser Cancer Therapy Hospitals , by Region USD Million (2018-2023)
  • Table 9. Laser Cancer Therapy Specialty Clinics , by Region USD Million (2018-2023)
  • Table 10. Laser Cancer Therapy Cancer and Radiation Therapy Centers , by Region USD Million (2018-2023)
  • Table 11. Laser Cancer Therapy: by Laser Therapy(USD Million)
  • Table 12. Laser Cancer Therapy Carbon dioxide (CO2) lasers , by Region USD Million (2018-2023)
  • Table 13. Laser Cancer Therapy Argon lasers , by Region USD Million (2018-2023)
  • Table 14. Laser Cancer Therapy Nd: Yag lasers , by Region USD Million (2018-2023)
  • Table 15. Laser Cancer Therapy: by Cancer(USD Million)
  • Table 16. Laser Cancer Therapy Blood Cancer , by Region USD Million (2018-2023)
  • Table 17. Laser Cancer Therapy Breast Cancer , by Region USD Million (2018-2023)
  • Table 18. Laser Cancer Therapy Prostate Cancer , by Region USD Million (2018-2023)
  • Table 19. Laser Cancer Therapy Gastrointestinal Cancer , by Region USD Million (2018-2023)
  • Table 20. Laser Cancer Therapy Others , by Region USD Million (2018-2023)
  • Table 21. South America Laser Cancer Therapy, by Country USD Million (2018-2023)
  • Table 22. South America Laser Cancer Therapy, by Application USD Million (2018-2023)
  • Table 23. South America Laser Cancer Therapy, by End-users USD Million (2018-2023)
  • Table 24. South America Laser Cancer Therapy, by Laser Therapy USD Million (2018-2023)
  • Table 25. South America Laser Cancer Therapy, by Cancer USD Million (2018-2023)
  • Table 26. Brazil Laser Cancer Therapy, by Application USD Million (2018-2023)
  • Table 27. Brazil Laser Cancer Therapy, by End-users USD Million (2018-2023)
  • Table 28. Brazil Laser Cancer Therapy, by Laser Therapy USD Million (2018-2023)
  • Table 29. Brazil Laser Cancer Therapy, by Cancer USD Million (2018-2023)
  • Table 30. Argentina Laser Cancer Therapy, by Application USD Million (2018-2023)
  • Table 31. Argentina Laser Cancer Therapy, by End-users USD Million (2018-2023)
  • Table 32. Argentina Laser Cancer Therapy, by Laser Therapy USD Million (2018-2023)
  • Table 33. Argentina Laser Cancer Therapy, by Cancer USD Million (2018-2023)
  • Table 34. Rest of South America Laser Cancer Therapy, by Application USD Million (2018-2023)
  • Table 35. Rest of South America Laser Cancer Therapy, by End-users USD Million (2018-2023)
  • Table 36. Rest of South America Laser Cancer Therapy, by Laser Therapy USD Million (2018-2023)
  • Table 37. Rest of South America Laser Cancer Therapy, by Cancer USD Million (2018-2023)
  • Table 38. Asia Pacific Laser Cancer Therapy, by Country USD Million (2018-2023)
  • Table 39. Asia Pacific Laser Cancer Therapy, by Application USD Million (2018-2023)
  • Table 40. Asia Pacific Laser Cancer Therapy, by End-users USD Million (2018-2023)
  • Table 41. Asia Pacific Laser Cancer Therapy, by Laser Therapy USD Million (2018-2023)
  • Table 42. Asia Pacific Laser Cancer Therapy, by Cancer USD Million (2018-2023)
  • Table 43. China Laser Cancer Therapy, by Application USD Million (2018-2023)
  • Table 44. China Laser Cancer Therapy, by End-users USD Million (2018-2023)
  • Table 45. China Laser Cancer Therapy, by Laser Therapy USD Million (2018-2023)
  • Table 46. China Laser Cancer Therapy, by Cancer USD Million (2018-2023)
  • Table 47. Japan Laser Cancer Therapy, by Application USD Million (2018-2023)
  • Table 48. Japan Laser Cancer Therapy, by End-users USD Million (2018-2023)
  • Table 49. Japan Laser Cancer Therapy, by Laser Therapy USD Million (2018-2023)
  • Table 50. Japan Laser Cancer Therapy, by Cancer USD Million (2018-2023)
  • Table 51. India Laser Cancer Therapy, by Application USD Million (2018-2023)
  • Table 52. India Laser Cancer Therapy, by End-users USD Million (2018-2023)
  • Table 53. India Laser Cancer Therapy, by Laser Therapy USD Million (2018-2023)
  • Table 54. India Laser Cancer Therapy, by Cancer USD Million (2018-2023)
  • Table 55. South Korea Laser Cancer Therapy, by Application USD Million (2018-2023)
  • Table 56. South Korea Laser Cancer Therapy, by End-users USD Million (2018-2023)
  • Table 57. South Korea Laser Cancer Therapy, by Laser Therapy USD Million (2018-2023)
  • Table 58. South Korea Laser Cancer Therapy, by Cancer USD Million (2018-2023)
  • Table 59. Taiwan Laser Cancer Therapy, by Application USD Million (2018-2023)
  • Table 60. Taiwan Laser Cancer Therapy, by End-users USD Million (2018-2023)
  • Table 61. Taiwan Laser Cancer Therapy, by Laser Therapy USD Million (2018-2023)
  • Table 62. Taiwan Laser Cancer Therapy, by Cancer USD Million (2018-2023)
  • Table 63. Australia Laser Cancer Therapy, by Application USD Million (2018-2023)
  • Table 64. Australia Laser Cancer Therapy, by End-users USD Million (2018-2023)
  • Table 65. Australia Laser Cancer Therapy, by Laser Therapy USD Million (2018-2023)
  • Table 66. Australia Laser Cancer Therapy, by Cancer USD Million (2018-2023)
  • Table 67. Rest of Asia-Pacific Laser Cancer Therapy, by Application USD Million (2018-2023)
  • Table 68. Rest of Asia-Pacific Laser Cancer Therapy, by End-users USD Million (2018-2023)
  • Table 69. Rest of Asia-Pacific Laser Cancer Therapy, by Laser Therapy USD Million (2018-2023)
  • Table 70. Rest of Asia-Pacific Laser Cancer Therapy, by Cancer USD Million (2018-2023)
  • Table 71. Europe Laser Cancer Therapy, by Country USD Million (2018-2023)
  • Table 72. Europe Laser Cancer Therapy, by Application USD Million (2018-2023)
  • Table 73. Europe Laser Cancer Therapy, by End-users USD Million (2018-2023)
  • Table 74. Europe Laser Cancer Therapy, by Laser Therapy USD Million (2018-2023)
  • Table 75. Europe Laser Cancer Therapy, by Cancer USD Million (2018-2023)
  • Table 76. Germany Laser Cancer Therapy, by Application USD Million (2018-2023)
  • Table 77. Germany Laser Cancer Therapy, by End-users USD Million (2018-2023)
  • Table 78. Germany Laser Cancer Therapy, by Laser Therapy USD Million (2018-2023)
  • Table 79. Germany Laser Cancer Therapy, by Cancer USD Million (2018-2023)
  • Table 80. France Laser Cancer Therapy, by Application USD Million (2018-2023)
  • Table 81. France Laser Cancer Therapy, by End-users USD Million (2018-2023)
  • Table 82. France Laser Cancer Therapy, by Laser Therapy USD Million (2018-2023)
  • Table 83. France Laser Cancer Therapy, by Cancer USD Million (2018-2023)
  • Table 84. Italy Laser Cancer Therapy, by Application USD Million (2018-2023)
  • Table 85. Italy Laser Cancer Therapy, by End-users USD Million (2018-2023)
  • Table 86. Italy Laser Cancer Therapy, by Laser Therapy USD Million (2018-2023)
  • Table 87. Italy Laser Cancer Therapy, by Cancer USD Million (2018-2023)
  • Table 88. United Kingdom Laser Cancer Therapy, by Application USD Million (2018-2023)
  • Table 89. United Kingdom Laser Cancer Therapy, by End-users USD Million (2018-2023)
  • Table 90. United Kingdom Laser Cancer Therapy, by Laser Therapy USD Million (2018-2023)
  • Table 91. United Kingdom Laser Cancer Therapy, by Cancer USD Million (2018-2023)
  • Table 92. Netherlands Laser Cancer Therapy, by Application USD Million (2018-2023)
  • Table 93. Netherlands Laser Cancer Therapy, by End-users USD Million (2018-2023)
  • Table 94. Netherlands Laser Cancer Therapy, by Laser Therapy USD Million (2018-2023)
  • Table 95. Netherlands Laser Cancer Therapy, by Cancer USD Million (2018-2023)
  • Table 96. Rest of Europe Laser Cancer Therapy, by Application USD Million (2018-2023)
  • Table 97. Rest of Europe Laser Cancer Therapy, by End-users USD Million (2018-2023)
  • Table 98. Rest of Europe Laser Cancer Therapy, by Laser Therapy USD Million (2018-2023)
  • Table 99. Rest of Europe Laser Cancer Therapy, by Cancer USD Million (2018-2023)
  • Table 100. MEA Laser Cancer Therapy, by Country USD Million (2018-2023)
  • Table 101. MEA Laser Cancer Therapy, by Application USD Million (2018-2023)
  • Table 102. MEA Laser Cancer Therapy, by End-users USD Million (2018-2023)
  • Table 103. MEA Laser Cancer Therapy, by Laser Therapy USD Million (2018-2023)
  • Table 104. MEA Laser Cancer Therapy, by Cancer USD Million (2018-2023)
  • Table 105. Middle East Laser Cancer Therapy, by Application USD Million (2018-2023)
  • Table 106. Middle East Laser Cancer Therapy, by End-users USD Million (2018-2023)
  • Table 107. Middle East Laser Cancer Therapy, by Laser Therapy USD Million (2018-2023)
  • Table 108. Middle East Laser Cancer Therapy, by Cancer USD Million (2018-2023)
  • Table 109. Africa Laser Cancer Therapy, by Application USD Million (2018-2023)
  • Table 110. Africa Laser Cancer Therapy, by End-users USD Million (2018-2023)
  • Table 111. Africa Laser Cancer Therapy, by Laser Therapy USD Million (2018-2023)
  • Table 112. Africa Laser Cancer Therapy, by Cancer USD Million (2018-2023)
  • Table 113. North America Laser Cancer Therapy, by Country USD Million (2018-2023)
  • Table 114. North America Laser Cancer Therapy, by Application USD Million (2018-2023)
  • Table 115. North America Laser Cancer Therapy, by End-users USD Million (2018-2023)
  • Table 116. North America Laser Cancer Therapy, by Laser Therapy USD Million (2018-2023)
  • Table 117. North America Laser Cancer Therapy, by Cancer USD Million (2018-2023)
  • Table 118. United States Laser Cancer Therapy, by Application USD Million (2018-2023)
  • Table 119. United States Laser Cancer Therapy, by End-users USD Million (2018-2023)
  • Table 120. United States Laser Cancer Therapy, by Laser Therapy USD Million (2018-2023)
  • Table 121. United States Laser Cancer Therapy, by Cancer USD Million (2018-2023)
  • Table 122. Canada Laser Cancer Therapy, by Application USD Million (2018-2023)
  • Table 123. Canada Laser Cancer Therapy, by End-users USD Million (2018-2023)
  • Table 124. Canada Laser Cancer Therapy, by Laser Therapy USD Million (2018-2023)
  • Table 125. Canada Laser Cancer Therapy, by Cancer USD Million (2018-2023)
  • Table 126. Mexico Laser Cancer Therapy, by Application USD Million (2018-2023)
  • Table 127. Mexico Laser Cancer Therapy, by End-users USD Million (2018-2023)
  • Table 128. Mexico Laser Cancer Therapy, by Laser Therapy USD Million (2018-2023)
  • Table 129. Mexico Laser Cancer Therapy, by Cancer USD Million (2018-2023)
  • Table 130. Company Basic Information, Sales Area and Its Competitors
  • Table 131. Company Basic Information, Sales Area and Its Competitors
  • Table 132. Company Basic Information, Sales Area and Its Competitors
  • Table 133. Company Basic Information, Sales Area and Its Competitors
  • Table 134. Company Basic Information, Sales Area and Its Competitors
  • Table 135. Company Basic Information, Sales Area and Its Competitors
  • Table 136. Company Basic Information, Sales Area and Its Competitors
  • Table 137. Company Basic Information, Sales Area and Its Competitors
  • Table 138. Company Basic Information, Sales Area and Its Competitors
  • Table 139. Company Basic Information, Sales Area and Its Competitors
  • Table 140. Laser Cancer Therapy: by Application(USD Million)
  • Table 141. Laser Cancer Therapy Dermatology and Aesthetics , by Region USD Million (2025-2030)
  • Table 142. Laser Cancer Therapy Dental , by Region USD Million (2025-2030)
  • Table 143. Laser Cancer Therapy Ophthalmology , by Region USD Million (2025-2030)
  • Table 144. Laser Cancer Therapy Cardiovascular , by Region USD Million (2025-2030)
  • Table 145. Laser Cancer Therapy Others , by Region USD Million (2025-2030)
  • Table 146. Laser Cancer Therapy: by End-users(USD Million)
  • Table 147. Laser Cancer Therapy Hospitals , by Region USD Million (2025-2030)
  • Table 148. Laser Cancer Therapy Specialty Clinics , by Region USD Million (2025-2030)
  • Table 149. Laser Cancer Therapy Cancer and Radiation Therapy Centers , by Region USD Million (2025-2030)
  • Table 150. Laser Cancer Therapy: by Laser Therapy(USD Million)
  • Table 151. Laser Cancer Therapy Carbon dioxide (CO2) lasers , by Region USD Million (2025-2030)
  • Table 152. Laser Cancer Therapy Argon lasers , by Region USD Million (2025-2030)
  • Table 153. Laser Cancer Therapy Nd: Yag lasers , by Region USD Million (2025-2030)
  • Table 154. Laser Cancer Therapy: by Cancer(USD Million)
  • Table 155. Laser Cancer Therapy Blood Cancer , by Region USD Million (2025-2030)
  • Table 156. Laser Cancer Therapy Breast Cancer , by Region USD Million (2025-2030)
  • Table 157. Laser Cancer Therapy Prostate Cancer , by Region USD Million (2025-2030)
  • Table 158. Laser Cancer Therapy Gastrointestinal Cancer , by Region USD Million (2025-2030)
  • Table 159. Laser Cancer Therapy Others , by Region USD Million (2025-2030)
  • Table 160. South America Laser Cancer Therapy, by Country USD Million (2025-2030)
  • Table 161. South America Laser Cancer Therapy, by Application USD Million (2025-2030)
  • Table 162. South America Laser Cancer Therapy, by End-users USD Million (2025-2030)
  • Table 163. South America Laser Cancer Therapy, by Laser Therapy USD Million (2025-2030)
  • Table 164. South America Laser Cancer Therapy, by Cancer USD Million (2025-2030)
  • Table 165. Brazil Laser Cancer Therapy, by Application USD Million (2025-2030)
  • Table 166. Brazil Laser Cancer Therapy, by End-users USD Million (2025-2030)
  • Table 167. Brazil Laser Cancer Therapy, by Laser Therapy USD Million (2025-2030)
  • Table 168. Brazil Laser Cancer Therapy, by Cancer USD Million (2025-2030)
  • Table 169. Argentina Laser Cancer Therapy, by Application USD Million (2025-2030)
  • Table 170. Argentina Laser Cancer Therapy, by End-users USD Million (2025-2030)
  • Table 171. Argentina Laser Cancer Therapy, by Laser Therapy USD Million (2025-2030)
  • Table 172. Argentina Laser Cancer Therapy, by Cancer USD Million (2025-2030)
  • Table 173. Rest of South America Laser Cancer Therapy, by Application USD Million (2025-2030)
  • Table 174. Rest of South America Laser Cancer Therapy, by End-users USD Million (2025-2030)
  • Table 175. Rest of South America Laser Cancer Therapy, by Laser Therapy USD Million (2025-2030)
  • Table 176. Rest of South America Laser Cancer Therapy, by Cancer USD Million (2025-2030)
  • Table 177. Asia Pacific Laser Cancer Therapy, by Country USD Million (2025-2030)
  • Table 178. Asia Pacific Laser Cancer Therapy, by Application USD Million (2025-2030)
  • Table 179. Asia Pacific Laser Cancer Therapy, by End-users USD Million (2025-2030)
  • Table 180. Asia Pacific Laser Cancer Therapy, by Laser Therapy USD Million (2025-2030)
  • Table 181. Asia Pacific Laser Cancer Therapy, by Cancer USD Million (2025-2030)
  • Table 182. China Laser Cancer Therapy, by Application USD Million (2025-2030)
  • Table 183. China Laser Cancer Therapy, by End-users USD Million (2025-2030)
  • Table 184. China Laser Cancer Therapy, by Laser Therapy USD Million (2025-2030)
  • Table 185. China Laser Cancer Therapy, by Cancer USD Million (2025-2030)
  • Table 186. Japan Laser Cancer Therapy, by Application USD Million (2025-2030)
  • Table 187. Japan Laser Cancer Therapy, by End-users USD Million (2025-2030)
  • Table 188. Japan Laser Cancer Therapy, by Laser Therapy USD Million (2025-2030)
  • Table 189. Japan Laser Cancer Therapy, by Cancer USD Million (2025-2030)
  • Table 190. India Laser Cancer Therapy, by Application USD Million (2025-2030)
  • Table 191. India Laser Cancer Therapy, by End-users USD Million (2025-2030)
  • Table 192. India Laser Cancer Therapy, by Laser Therapy USD Million (2025-2030)
  • Table 193. India Laser Cancer Therapy, by Cancer USD Million (2025-2030)
  • Table 194. South Korea Laser Cancer Therapy, by Application USD Million (2025-2030)
  • Table 195. South Korea Laser Cancer Therapy, by End-users USD Million (2025-2030)
  • Table 196. South Korea Laser Cancer Therapy, by Laser Therapy USD Million (2025-2030)
  • Table 197. South Korea Laser Cancer Therapy, by Cancer USD Million (2025-2030)
  • Table 198. Taiwan Laser Cancer Therapy, by Application USD Million (2025-2030)
  • Table 199. Taiwan Laser Cancer Therapy, by End-users USD Million (2025-2030)
  • Table 200. Taiwan Laser Cancer Therapy, by Laser Therapy USD Million (2025-2030)
  • Table 201. Taiwan Laser Cancer Therapy, by Cancer USD Million (2025-2030)
  • Table 202. Australia Laser Cancer Therapy, by Application USD Million (2025-2030)
  • Table 203. Australia Laser Cancer Therapy, by End-users USD Million (2025-2030)
  • Table 204. Australia Laser Cancer Therapy, by Laser Therapy USD Million (2025-2030)
  • Table 205. Australia Laser Cancer Therapy, by Cancer USD Million (2025-2030)
  • Table 206. Rest of Asia-Pacific Laser Cancer Therapy, by Application USD Million (2025-2030)
  • Table 207. Rest of Asia-Pacific Laser Cancer Therapy, by End-users USD Million (2025-2030)
  • Table 208. Rest of Asia-Pacific Laser Cancer Therapy, by Laser Therapy USD Million (2025-2030)
  • Table 209. Rest of Asia-Pacific Laser Cancer Therapy, by Cancer USD Million (2025-2030)
  • Table 210. Europe Laser Cancer Therapy, by Country USD Million (2025-2030)
  • Table 211. Europe Laser Cancer Therapy, by Application USD Million (2025-2030)
  • Table 212. Europe Laser Cancer Therapy, by End-users USD Million (2025-2030)
  • Table 213. Europe Laser Cancer Therapy, by Laser Therapy USD Million (2025-2030)
  • Table 214. Europe Laser Cancer Therapy, by Cancer USD Million (2025-2030)
  • Table 215. Germany Laser Cancer Therapy, by Application USD Million (2025-2030)
  • Table 216. Germany Laser Cancer Therapy, by End-users USD Million (2025-2030)
  • Table 217. Germany Laser Cancer Therapy, by Laser Therapy USD Million (2025-2030)
  • Table 218. Germany Laser Cancer Therapy, by Cancer USD Million (2025-2030)
  • Table 219. France Laser Cancer Therapy, by Application USD Million (2025-2030)
  • Table 220. France Laser Cancer Therapy, by End-users USD Million (2025-2030)
  • Table 221. France Laser Cancer Therapy, by Laser Therapy USD Million (2025-2030)
  • Table 222. France Laser Cancer Therapy, by Cancer USD Million (2025-2030)
  • Table 223. Italy Laser Cancer Therapy, by Application USD Million (2025-2030)
  • Table 224. Italy Laser Cancer Therapy, by End-users USD Million (2025-2030)
  • Table 225. Italy Laser Cancer Therapy, by Laser Therapy USD Million (2025-2030)
  • Table 226. Italy Laser Cancer Therapy, by Cancer USD Million (2025-2030)
  • Table 227. United Kingdom Laser Cancer Therapy, by Application USD Million (2025-2030)
  • Table 228. United Kingdom Laser Cancer Therapy, by End-users USD Million (2025-2030)
  • Table 229. United Kingdom Laser Cancer Therapy, by Laser Therapy USD Million (2025-2030)
  • Table 230. United Kingdom Laser Cancer Therapy, by Cancer USD Million (2025-2030)
  • Table 231. Netherlands Laser Cancer Therapy, by Application USD Million (2025-2030)
  • Table 232. Netherlands Laser Cancer Therapy, by End-users USD Million (2025-2030)
  • Table 233. Netherlands Laser Cancer Therapy, by Laser Therapy USD Million (2025-2030)
  • Table 234. Netherlands Laser Cancer Therapy, by Cancer USD Million (2025-2030)
  • Table 235. Rest of Europe Laser Cancer Therapy, by Application USD Million (2025-2030)
  • Table 236. Rest of Europe Laser Cancer Therapy, by End-users USD Million (2025-2030)
  • Table 237. Rest of Europe Laser Cancer Therapy, by Laser Therapy USD Million (2025-2030)
  • Table 238. Rest of Europe Laser Cancer Therapy, by Cancer USD Million (2025-2030)
  • Table 239. MEA Laser Cancer Therapy, by Country USD Million (2025-2030)
  • Table 240. MEA Laser Cancer Therapy, by Application USD Million (2025-2030)
  • Table 241. MEA Laser Cancer Therapy, by End-users USD Million (2025-2030)
  • Table 242. MEA Laser Cancer Therapy, by Laser Therapy USD Million (2025-2030)
  • Table 243. MEA Laser Cancer Therapy, by Cancer USD Million (2025-2030)
  • Table 244. Middle East Laser Cancer Therapy, by Application USD Million (2025-2030)
  • Table 245. Middle East Laser Cancer Therapy, by End-users USD Million (2025-2030)
  • Table 246. Middle East Laser Cancer Therapy, by Laser Therapy USD Million (2025-2030)
  • Table 247. Middle East Laser Cancer Therapy, by Cancer USD Million (2025-2030)
  • Table 248. Africa Laser Cancer Therapy, by Application USD Million (2025-2030)
  • Table 249. Africa Laser Cancer Therapy, by End-users USD Million (2025-2030)
  • Table 250. Africa Laser Cancer Therapy, by Laser Therapy USD Million (2025-2030)
  • Table 251. Africa Laser Cancer Therapy, by Cancer USD Million (2025-2030)
  • Table 252. North America Laser Cancer Therapy, by Country USD Million (2025-2030)
  • Table 253. North America Laser Cancer Therapy, by Application USD Million (2025-2030)
  • Table 254. North America Laser Cancer Therapy, by End-users USD Million (2025-2030)
  • Table 255. North America Laser Cancer Therapy, by Laser Therapy USD Million (2025-2030)
  • Table 256. North America Laser Cancer Therapy, by Cancer USD Million (2025-2030)
  • Table 257. United States Laser Cancer Therapy, by Application USD Million (2025-2030)
  • Table 258. United States Laser Cancer Therapy, by End-users USD Million (2025-2030)
  • Table 259. United States Laser Cancer Therapy, by Laser Therapy USD Million (2025-2030)
  • Table 260. United States Laser Cancer Therapy, by Cancer USD Million (2025-2030)
  • Table 261. Canada Laser Cancer Therapy, by Application USD Million (2025-2030)
  • Table 262. Canada Laser Cancer Therapy, by End-users USD Million (2025-2030)
  • Table 263. Canada Laser Cancer Therapy, by Laser Therapy USD Million (2025-2030)
  • Table 264. Canada Laser Cancer Therapy, by Cancer USD Million (2025-2030)
  • Table 265. Mexico Laser Cancer Therapy, by Application USD Million (2025-2030)
  • Table 266. Mexico Laser Cancer Therapy, by End-users USD Million (2025-2030)
  • Table 267. Mexico Laser Cancer Therapy, by Laser Therapy USD Million (2025-2030)
  • Table 268. Mexico Laser Cancer Therapy, by Cancer USD Million (2025-2030)
  • Table 269. Research Programs/Design for This Report
  • Table 270. Key Data Information from Secondary Sources
  • Table 271. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Laser Cancer Therapy: by Application USD Million (2018-2023)
  • Figure 5. Global Laser Cancer Therapy: by End-users USD Million (2018-2023)
  • Figure 6. Global Laser Cancer Therapy: by Laser Therapy USD Million (2018-2023)
  • Figure 7. Global Laser Cancer Therapy: by Cancer USD Million (2018-2023)
  • Figure 8. South America Laser Cancer Therapy Share (%), by Country
  • Figure 9. Asia Pacific Laser Cancer Therapy Share (%), by Country
  • Figure 10. Europe Laser Cancer Therapy Share (%), by Country
  • Figure 11. MEA Laser Cancer Therapy Share (%), by Country
  • Figure 12. North America Laser Cancer Therapy Share (%), by Country
  • Figure 13. Global Laser Cancer Therapy share by Players 2023 (%)
  • Figure 14. Global Laser Cancer Therapy share by Players (Top 3) 2023(%)
  • Figure 15. Global Laser Cancer Therapy share by Players (Top 5) 2023(%)
  • Figure 16. BCG Matrix for key Companies
  • Figure 17. Biolase Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 18. Biolase Inc. (United States) Revenue: by Geography 2023
  • Figure 19. Alma Lasers (Israel) Revenue, Net Income and Gross profit
  • Figure 20. Alma Lasers (Israel) Revenue: by Geography 2023
  • Figure 21. Cutera (United States) Revenue, Net Income and Gross profit
  • Figure 22. Cutera (United States) Revenue: by Geography 2023
  • Figure 23. IRIDEX Corp. (United States) Revenue, Net Income and Gross profit
  • Figure 24. IRIDEX Corp. (United States) Revenue: by Geography 2023
  • Figure 25. Valeant (Canada) Revenue, Net Income and Gross profit
  • Figure 26. Valeant (Canada) Revenue: by Geography 2023
  • Figure 27. Coherent, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 28. Coherent, Inc. (United States) Revenue: by Geography 2023
  • Figure 29. Angiodynamics, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 30. Angiodynamics, Inc. (United States) Revenue: by Geography 2023
  • Figure 31. Boston Scientific Corporation (United States) Revenue, Net Income and Gross profit
  • Figure 32. Boston Scientific Corporation (United States) Revenue: by Geography 2023
  • Figure 33. BTL (United States) Revenue, Net Income and Gross profit
  • Figure 34. BTL (United States) Revenue: by Geography 2023
  • Figure 35. Meditech International Inc. (BIOFLEX Laser Therapy) (United States) Revenue, Net Income and Gross profit
  • Figure 36. Meditech International Inc. (BIOFLEX Laser Therapy) (United States) Revenue: by Geography 2023
  • Figure 37. Global Laser Cancer Therapy: by Application USD Million (2025-2030)
  • Figure 38. Global Laser Cancer Therapy: by End-users USD Million (2025-2030)
  • Figure 39. Global Laser Cancer Therapy: by Laser Therapy USD Million (2025-2030)
  • Figure 40. Global Laser Cancer Therapy: by Cancer USD Million (2025-2030)
  • Figure 41. South America Laser Cancer Therapy Share (%), by Country
  • Figure 42. Asia Pacific Laser Cancer Therapy Share (%), by Country
  • Figure 43. Europe Laser Cancer Therapy Share (%), by Country
  • Figure 44. MEA Laser Cancer Therapy Share (%), by Country
  • Figure 45. North America Laser Cancer Therapy Share (%), by Country
List of companies from research coverage that are profiled in the study
  • Biolase Inc. (United States)
  • Alma Lasers (Israel)
  • Cutera (United States)
  • IRIDEX Corp. (United States)
  • Valeant (Canada)
  • Coherent, Inc. (United States)
  • Angiodynamics, Inc. (United States)
  • Boston Scientific Corporation (United States)
  • BTL (United States)
  • Meditech International Inc. (BIOFLEX Laser Therapy) (United States)
Additional players considered in the study are as follows:
Baring Private Equity Asia Ltd (Lumenis) (Hong Kong) , Biolitec AG UntereViaduktgasse (Austria) , Hologic Inc., (United States)
Select User Access Type

Key Highlights of Report


Mar 2024 245 Pages 68 Tables Base Year: 2023 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Laser Cancer Therapy Market Quantitative research analysis
Global Laser Cancer Therapy Market Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

The key segments that are playing vital role in Laser Cancer Therapy Market are by end use application [Dermatology and Aesthetics, Dental, Ophthalmology, Cardiovascular and Others].
The Laser Cancer Therapy Market is gaining popularity and expected to see strong valuation by 2030.
  • Increasing Consumer Preference towards Innovative Laser-Based Technologies
  • Growing Prevalence of Diseases like Cataract and Arthritis

Know More About Global Laser Cancer Therapy Market Report?

Have a Query? Click Here

Other Related Reports

Occupational Health and Safety Software Comprehensive Study by Type (Cloud-Based, Web-Based), Application (Employee Health Management, Compliance Tracking, Incident Management,, Medical Surveillance,...
$ 3800
Smart Vision Aids Comprehensive Study by Type (Audio-visual Conversion, Implantable BMI, Non-implantable BMI), Application (Central Vision Loss, Blurry Vision, Blind Spot, Others), Product Type (Smar...
$ 3800
Metaverse in Healthcare Comprehensive Study by Technology (Virtual Reality, Augmented Reality, Mixed Reality, Artificial Intelligence), Device (Virtual Reality Headsets, Augmented Reality Devices, Mi...
$ 3800
VR in Elderly Care Comprehensive Study by Type (Non-immersive Virtual Reality, Fully Immersive Virtual Reality, Semi-Immersive Virtual Reality, Augmented Reality, Collaborative VR), Application (Medi...
$ 3800
Wellness App Comprehensive Study by Type (Exercise and Weight Loss, Diet and Nutrition, Activity Tracking, Others), Device (Smartphones, Tablets, Wearable Devices), Operating system (IOS, Android) Pl...
$ 3800
Healthcare Additive Manufacturing Comprehensive Study by Application (Medical Implants, Prosthetics, Wearable Devices, Tissue Engineering, Others), Technology (Stereolithography, Deposition Modeling,...
$ 3800